Unknown

Dataset Information

0

Hydroxypropyl-?-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.


ABSTRACT: Studies suggest that altered renal lipid metabolism plays a role in the pathogenesis of diabetic kidney disease and that genetic or pharmacological induction of cholesterol efflux protects from the development of diabetic kidney disease and focal segmental glomerulosclerosis (FSGS). Here we tested whether altered lipid metabolism contributes to renal failure in the Col4a3 knockout mouse model for Alport Syndrome. There was an eight-fold increase in the cholesterol content in renal cortexes of mice with Alport Syndrome. This was associated with increased glomerular lipid droplets and cholesterol crystals. Treatment of mice with Alport Syndrome with hydroxypropyl-?-cyclodextrin (HP?CD) reduced cholesterol content in the kidneys of mice with Alport Syndrome and protected from the development of albuminuria, renal failure, inflammation and tubulointerstitial fibrosis. Cholesterol efflux and trafficking-related genes were primarily affected in mice with Alport Syndrome and were differentially regulated in the kidney cortex and isolated glomeruli. HP?CD also protected from proteinuria and mesangial expansion in a second model of non-metabolic kidney disease, adriamycin-induced nephropathy. Consistent with our experimental findings, microarray analysis confirmed dysregulation of several lipid-related genes in glomeruli isolated from kidney biopsies of patients with primary FSGS enrolled in the NEPTUNE study. Thus, lipid dysmetabolism occurs in non-metabolic glomerular disorders such as Alport Syndrome and FSGS, and HP?CD improves renal function in experimental Alport Syndrome and FSGS.

SUBMITTER: Mitrofanova A 

PROVIDER: S-EPMC6278936 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6655412 | BioStudies
2019-01-01 | S-EPMC6386959 | BioStudies
2017-01-01 | S-EPMC5696060 | BioStudies
1000-01-01 | S-EPMC6251900 | BioStudies
2011-01-01 | S-EPMC3231786 | BioStudies
1000-01-01 | S-EPMC4974872 | BioStudies
2014-01-01 | S-EPMC4245465 | BioStudies
2012-01-01 | S-EPMC3517557 | BioStudies
2017-01-01 | S-EPMC5619963 | BioStudies
2018-01-01 | S-EPMC5926939 | BioStudies